Revenue Summary of Novartis AG

Novartis AG's latest annual revenue in 2023 was 46.66 Billion USD , down -9.97% from previous year.
Novartis AG's latest quarterly revenue in 2024 Q1 was 12.12 Billion USD , up 2.92% from previous quarter.
Novartis AG reported a annual revenue of 51.82 Billion USD in annual revenue 2022, down -1.98% from previous year.
Novartis AG reported a annual revenue of 52.87 Billion USD in annual revenue 2021, up 5.97% from previous year.
Novartis AG reported a quarterly revenue of 12.12 Billion USD for 2024 Q1, up 2.92% from previous quarter.
Novartis AG reported a quarterly revenue of 13.17 Billion USD for 2024 Q3, up 2.33% from previous quarter.

Annual Revenue Chart of Novartis AG (2023 - 1998)

Historical Annual Revenue of Novartis AG (2023 - 1998)

Year	Revenue	Revenue Growth
2023	46.66 Billion USD	-9.97%
2022	51.82 Billion USD	-1.98%
2021	52.87 Billion USD	5.97%
2020	49.89 Billion USD	2.51%
2019	48.67 Billion USD	-8.44%
2018	53.16 Billion USD	6.05%
2017	50.13 Billion USD	1.41%
2016	49.43 Billion USD	-1.89%
2015	50.38 Billion USD	-6.05%
2014	53.63 Billion USD	-8.83%
2013	58.83 Billion USD	2.21%
2012	57.56 Billion USD	-3.06%
2011	59.37 Billion USD	15.15%
2010	51.56 Billion USD	14.32%
2009	45.1 Billion USD	5.92%
2008	42.58 Billion USD	9.34%
2007	38.94 Billion USD	5.98%
2006	36.74 Billion USD	12.98%
2005	32.52 Billion USD	15.15%
2004	28.24 Billion USD	13.61%
2003	24.86 Billion USD	7.4%
2002	23.15 Billion USD	19.74%
2001	19.33 Billion USD	-11.44%
2000	21.83 Billion USD	6.93%
1999	20.41 Billion USD	-11.38%
1998	23.03 Billion USD	0.0%

Year	Revenue	Revenue Growth
2024 Q2	12.87 Billion USD	6.2%
2024 Q1	12.12 Billion USD	2.92%
2024 Q3	13.17 Billion USD	2.33%
2023 FY	46.66 Billion USD	-9.97%
2023 Q2	13.93 Billion USD	5.51%
2023 Q1	13.2 Billion USD	0.92%
2023 Q3	12.09 Billion USD	-13.23%
2023 Q4	11.77 Billion USD	-2.61%
2022 Q2	13.08 Billion USD	2.11%
2022 Q3	12.84 Billion USD	-1.86%
2022 Q4	13.08 Billion USD	1.91%
2022 FY	51.82 Billion USD	-1.98%
2022 Q1	12.81 Billion USD	-5.24%
2021 Q2	13.29 Billion USD	4.73%
2021 Q3	13.36 Billion USD	0.55%
2021 Q4	13.52 Billion USD	1.16%
2021 FY	52.87 Billion USD	5.97%
2021 Q1	12.69 Billion USD	-2.58%
2020 FY	49.89 Billion USD	2.51%
2020 Q2	11.62 Billion USD	-8.55%
2020 Q1	12.7 Billion USD	-0.06%
2020 Q3	12.53 Billion USD	7.88%
2020 Q4	13.03 Billion USD	3.92%
2019 Q2	12.02 Billion USD	4.97%
2019 Q3	12.48 Billion USD	3.81%
2019 FY	48.67 Billion USD	-8.44%
2019 Q4	12.71 Billion USD	1.87%
2019 Q1	11.45 Billion USD	-16.17%
2018 Q1	12.92 Billion USD	-1.79%
2018 Q3	11.38 Billion USD	-15.36%
2018 FY	53.16 Billion USD	6.05%
2018 Q4	13.66 Billion USD	20.01%
2018 Q2	13.45 Billion USD	4.05%
2017 Q2	12.49 Billion USD	6.02%
2017 FY	50.13 Billion USD	1.41%
2017 Q4	13.16 Billion USD	3.72%
2017 Q3	12.69 Billion USD	1.58%
2017 Q1	11.78 Billion USD	-6.51%
2016 Q4	12.6 Billion USD	2.15%
2016 FY	49.43 Billion USD	-1.89%
2016 Q1	11.81 Billion USD	-7.76%
2016 Q2	12.67 Billion USD	7.36%
2016 Q3	12.34 Billion USD	-2.67%
2015 Q4	12.8 Billion USD	2.56%
2015 Q2	12.89 Billion USD	5.69%
2015 Q1	12.2 Billion USD	-8.63%
2015 FY	50.38 Billion USD	-6.05%
2015 Q3	12.48 Billion USD	-3.19%
2014 Q2	13.94 Billion USD	-2.04%
2014 Q1	14.23 Billion USD	-7.32%
2014 FY	53.63 Billion USD	-8.83%
2014 Q4	13.35 Billion USD	0.41%
2014 Q3	13.3 Billion USD	-4.65%
2013 Q3	14.55 Billion USD	-0.99%
2013 FY	58.83 Billion USD	2.21%
2013 Q2	14.7 Billion USD	3.51%
2013 Q1	14.2 Billion USD	-5.72%
2013 Q4	15.36 Billion USD	5.53%
2012 FY	57.56 Billion USD	-3.06%
2012 Q1	13.91 Billion USD	-7.22%
2012 Q4	15.06 Billion USD	7.33%
2012 Q3	14.03 Billion USD	-3.45%
2012 Q2	14.54 Billion USD	4.51%
2011 Q3	15.03 Billion USD	-0.59%
2011 FY	59.37 Billion USD	15.15%
2011 Q2	15.12 Billion USD	6.34%
2011 Q1	14.22 Billion USD	-1.67%
2011 Q4	14.99 Billion USD	-0.25%
2010 Q1	12.35 Billion USD	-6.0%
2010 FY	51.56 Billion USD	14.32%
2010 Q4	14.46 Billion USD	12.82%
2010 Q3	12.82 Billion USD	7.54%
2010 Q2	11.92 Billion USD	-3.52%
2009 Q1	9.92 Billion USD	-4.08%
2009 FY	45.1 Billion USD	5.92%
2009 Q4	13.14 Billion USD	16.43%
2009 Q3	11.29 Billion USD	5.1%
2009 Q2	10.74 Billion USD	8.22%
2008 Q4	10.34 Billion USD	-6.18%
2008 FY	42.58 Billion USD	9.34%
2008 Q3	11.03 Billion USD	2.83%
2008 Q2	10.72 Billion USD	4.99%
2008 Q1	10.21 Billion USD	0.44%
2007 FY	38.94 Billion USD	5.98%
2007 Q1	9.81 Billion USD	5.35%
2007 Q2	9.4 Billion USD	-4.26%
2007 Q3	9.81 Billion USD	4.45%
2007 Q4	10.17 Billion USD	3.6%
2006 Q4	9.31 Billion USD	-3.83%
2006 Q2	9.18 Billion USD	10.61%
2006 Q1	8.3 Billion USD	-5.16%
2006 Q3	9.69 Billion USD	5.53%
2006 FY	36.74 Billion USD	12.98%
2005 Q1	7.34 Billion USD	-3.13%
2005 Q3	8.48 Billion USD	7.87%
2005 Q2	7.87 Billion USD	7.21%
2005 Q4	8.75 Billion USD	3.11%
2005 FY	32.52 Billion USD	15.15%
2004 Q4	7.57 Billion USD	7.38%
2004 Q2	6.97 Billion USD	5.03%
2004 Q3	7.05 Billion USD	1.2%
2004 Q1	6.63 Billion USD	-1.35%
2004 FY	28.24 Billion USD	13.61%
2003 Q4	6.73 Billion USD	8.37%
2003 FY	24.86 Billion USD	7.4%
2003 Q2	6.2 Billion USD	8.43%
2003 Q1	5.72 Billion USD	-26.7%
2003 Q3	6.21 Billion USD	0.11%
2002 Q4	7.8 Billion USD	54.28%
2002 Q3	5.05 Billion USD	-9.63%
2002 Q2	5.59 Billion USD	15.23%
2002 Q1	4.85 Billion USD	-5.45%
2002 FY	23.15 Billion USD	19.74%
2001 Q2	4.31 Billion USD	-2.91%
2001 Q1	4.44 Billion USD	-25.52%
2001 Q4	5.13 Billion USD	-7.86%
2001 FY	19.33 Billion USD	-11.44%
2001 Q3	5.57 Billion USD	29.34%
2000 Q4	5.96 Billion USD	22.13%
2000 Q2	5.8 Billion USD	1.91%
2000 Q3	4.88 Billion USD	-15.93%
2000 Q1	5.69 Billion USD	0.0%
2000 FY	21.83 Billion USD	6.93%
1999 FY	20.41 Billion USD	-11.38%
1998 FY	23.03 Billion USD	0.0%

Peer Revenue Comparison of Novartis AG

Name	Revenue	Revenue Difference
Roche Holding AG	58.71 Billion CHF	20.533%
Roche Holding AG	58.71 Billion CHF	20.533%

Global Stocks Search

Novartis AG (NOVN.SW)

Revenue Summary of Novartis AG

Annual Revenue Chart of Novartis AG (2023 - 1998)

Historical Annual Revenue of Novartis AG (2023 - 1998)

Peer Revenue Comparison of Novartis AG